BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

JS Genetics Announce Launch of its Bloodless, Cheek Swab Test for Fragile X Syndrome


4/18/2012 10:19:21 AM

NEW HAVEN Conn., April 18, 2012 /PRNewswire/ -- JS Genetics announces the launch of XCAT-FX, its propitiatory buccal swab test for the detection of Fragile X syndrome. Fragile X syndrome is the most common cause of inherited intellectual disability (mental retardation) in males and a leading cause of infertility and fragile X-associated primary ovarian insufficiency in females. Fragile X is also the most common known genetic (single gene) cause of autism. This PCR based test can identify Fragile X in both males and female patients.

The result of XCAT-FX will typically be available within 3 business days following the receipt of the samples at JS Genetics' CLIA certified, CAP accredited laboratory.

"I am very pleased that we are now including Fragile X in the JS Genetics diagnostic menu," stated Henry Rinder MD, Medical Director of JS Genetics. "Fragile X testing will further enhance our laboratory's ability to aid physicians in making the sometimes difficult diagnosis of disorders of sex chromosomes, which also include Turner and Klinefelter syndromes and related sex chromosome aneuploidies."

About JS Genetics
For more information about JS Genetics or XCAT-FX visit www.jsgenetics.com. Physicians who would like to obtain testing kits at no charge can order at www.jsgenetics.com or call1-888-217-8947.

JS Genetics Inc., a private company, develops and markets proprietary, high value DNA diagnostic tests for medical conditions in newborns, children, and adolescents. (CLIA ID# 07D1091103; CAP# 72115351)

SOURCE JS Genetics



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES